Source: Markets Insider

Stemedica: Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19

SAN DIEGO, May 24, 2021 /PRNewswire/ -- Stemedica Cell Technologies, Inc. ('Stemedica'), a San Diego-based biotech company specializing in the man...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Maynard A. Howe's photo - CEO of Stemedica

CEO

Maynard A. Howe

CEO Approval Rating

70/100

Read more